TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11244515

Group type: EXPERIMENTAL
Intervention: Carvedilol after coronary atherectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel atherectomy device in the Pullback Atherectomy (PAC) pilot trial
Number of subjects: 0
Study: 8866633

Group type: EXPERIMENTAL
Intervention: 250 mg quinine
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 500 mg quinine
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 1000 mg quinine
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: All doses (250, 500, 1000 mg)
Number of subjects: 7
Study: 1948128

Group type: EXPERIMENTAL
Intervention: Continuous interferon-alfa-2b at a dose of 5 x 10(6) IU subcutaneously three times per week
Number of subjects: 120

Group type: COMPARATOR
Intervention: No further therapy
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Continuous interferon-alfa-2b
Number of subjects: 120
Study: 6503213

Group type: EXPERIMENTAL
Intervention: Bicarbonate buffer during hemodialysis, hemofiltration, and hemodiafiltration
Number of subjects: 5

Group type: COMPARATOR
Intervention: Acetate buffer during hemodialysis
Number of subjects: 5

Group type: COMPARATOR
Intervention: Acetate buffer during hemofiltration
Number of subjects: 5
Study: 31527240

Group type: EXPERIMENTAL
Intervention: Positive, nonenforcement contact with uniformed police officers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 29334906

Group type: EXPERIMENTAL
Intervention: Linagliptin (5 mg)
Number of subjects: 6042

Group type: COMPARATOR
Intervention: Glimepiride (1-4 mg)
Number of subjects: 6042
Study: 26725476

Group type: EXPERIMENTAL
Intervention: Guided internet-RFCBT
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Unguided internet-RFCBT
Number of subjects: 251

Group type: COMPARATOR
Intervention: No-intervention control
Number of subjects: 251
Study: 22144347

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Waiting list (WL)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Combined groups (post-MBSR)
Number of subjects: 56
Study: 20058261

Group type: EXPERIMENTAL
Intervention: Variable-stiffness shoe
Number of subjects: 60

Group type: COMPARATOR
Intervention: Constant-stiffness control shoe
Number of subjects: 60
Study: 18833113

Group type: EXPERIMENTAL
Intervention: Xydifonum administered via various modes (electrophoretic, peroral, ointment) with heparin and photopheresis using photomatrix LED equipment.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (non-operated patients) receiving standard treatment without xydifonum.
Number of subjects: 80
Study: 16422309

Group type: EXPERIMENTAL
Intervention: Surgically implanted left ventricular assist device
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 14601013

Group type: EXPERIMENTAL
Intervention: Various treatments for hyperactivity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Confidence level assignment method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bootstrap method for confidence levels
Number of subjects: 0
Study: 10565503

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Desipramine
Number of subjects: 40
Study: 8877012

Group type: EXPERIMENTAL
Intervention: Tamoxifen (30 mg daily for 1 year)
Number of subjects: 1716

Group type: COMPARATOR
Intervention: Control (local radiotherapy without tamoxifen)
Number of subjects: 1716
Study: 2065412

Group type: EXPERIMENTAL
Intervention: 100 micrograms of fentanyl with 8 ml preservative‐free normal saline
Number of subjects: 40

Group type: COMPARATOR
Intervention: 10 ml of preservative‐free normal saline via the epidural catheter
Number of subjects: 40
Study: 6371525

Group type: EXPERIMENTAL
Intervention: Predictive instrument for acute cardiac ischemia diagnosis
Number of subjects: 2320

Group type: COMPARATOR
Intervention: Standard diagnostic practices without the predictive instrument
Number of subjects: 2320
Study: 28151019

Group type: EXPERIMENTAL
Intervention: SNAP Program
Number of subjects: 252

Group type: COMPARATOR
Intervention: Standard services
Number of subjects: 252
Study: 29722045

Group type: EXPERIMENTAL
Intervention: Body Project intervention (n = 17) - participants tracked daily diet and activity, attended four weekly group-based sessions
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard group (n = 15) - directed to track diet and activity level daily
Number of subjects: 32
Study: 26035740

Group type: EXPERIMENTAL
Intervention: Caffeine capsules (200 mg) plus 10% carbohydrate mouth rinse (CAFF + CMR)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 10% carbohydrate mouth rinse (CMR)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo capsules and placebo mouth rinse (PLACEBO)
Number of subjects: 8
Study: 25310121

Group type: EXPERIMENTAL
Intervention: Mother support groups (MSGs) at 15 health facilities
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard-of-care
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mother support groups (MSGs)
Number of subjects: 30
Study: 22681723

Group type: EXPERIMENTAL
Intervention: Donepezil 23 mg/day
Number of subjects: 902
Study: 19570066

Group type: EXPERIMENTAL
Intervention: Draw-the-Family Test (DFT) administered to patients with benign anorectal disease
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Draw-the-Family Test (DFT) administered to patients with organic disease
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Draw-the-Family Test (DFT) administered to patients who failed treatment
Number of subjects: 62

Group type: COMPARATOR
Intervention: Draw-the-Family Test (DFT) administered to healthy control subjects
Number of subjects: 62
Study: 16644036

Group type: COMPARATOR
Intervention: Protocol A (step-up energy protocol): (1) 200 J anteroapical, (2) 360 J anteroapical, (3) 360 J anteroposterior
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Protocol B (high initial energy shock protocol): (1) 360 J anteroapical, (2) 360 J anteroposterior, (3) 360 J posteroanterior
Number of subjects: 261
Study: 17095947

Group type: EXPERIMENTAL
Intervention: Sodium-selenite (1000 microg as a 30-min bolus injection, followed by 14 daily continuous infusions of 1000 microg intravenously)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Sodium-selenite
Number of subjects: 238

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 238
Study: 14985680

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (4 g/day, 56% DHA and 28% EPA)
Number of subjects: 83
Study: 10837185

Group type: EXPERIMENTAL
Intervention: Pyrimethamine plus sulfadoxine (PM/SD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chlorproguanil/dapsone (CPG/Dap)
Number of subjects: 0
Study: 9049571

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 605

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 605
Study: 8211620

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (Group V)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Conventional cholecystectomy + injection of 20 ml bupivacaine 0.5% into the mesentery root (Group II)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Conventional cholecystectomy + 7.5 mg propranolol i.v. and 0.5 mg neostigmine s.c. (Group III)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Conventional cholecystectomy + bupivacaine + propranolol and neostigmine (Group IV)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional cholecystectomy (Control Group)
Number of subjects: 100
Study: 2947723

Group type: EXPERIMENTAL
Intervention: Kangdu pellet
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (16 cases)
Number of subjects: 25
Study: 11323442

Group type: EXPERIMENTAL
Intervention: Increase Fruit and Vegetable intake
Number of subjects: 0

Group type: COMPARATOR
Intervention: Decrease high-fat/high-sugar intake
Number of subjects: 0
Study: 31243641

Group type: EXPERIMENTAL
Intervention: Macuprev® supplementation (two tablets/day for 6 months)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (two tablets/day for 6 months)
Number of subjects: 30
Study: 30042488

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MED)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Central European diet (CED)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: More adherent participants in both diet groups
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: More adherent participants in CED
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Both diets (CED and MED)
Number of subjects: 144
Study: 26632030

Group type: EXPERIMENTAL
Intervention: Heart transplantation after listing for heart transplantation
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Factors associated with listing for heart transplantation
Number of subjects: 555

Group type: COMPARATOR
Intervention: Post-Norwood procedure care
Number of subjects: 555
Study: 24903630

Group type: EXPERIMENTAL
Intervention: Mild-moderate endurance exercise (20-min submaximal cycling at ≈45 Watts)
Number of subjects: 26
Study: 22624251

Group type: EXPERIMENTAL
Intervention: Radiographic method for PLC isometric point
Number of subjects: 20

Group type: COMPARATOR
Intervention: Anatomic method for PLC isometric point
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Radiographic method for posteromedial side
Number of subjects: 20

Group type: COMPARATOR
Intervention: Anatomic method for posteromedial side
Number of subjects: 20
Study: 20203367

Group type: EXPERIMENTAL
Intervention: Vitamin E (200 mg p/o from the preoperative day till the 7th postoperative day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no vitamin E treatment)
Number of subjects: 32
Study: 17395046

Group type: EXPERIMENTAL
Intervention: Resistance training (RT) for 11 weeks (n = 7)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Usual care (C) for 11 weeks (n = 6)
Number of subjects: 13
Study: 16190847

Group type: EXPERIMENTAL
Intervention: Standard TURP
Number of subjects: 161

Group type: COMPARATOR
Intervention: Prostatic hemiresection
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 161
Study: 12189059

Group type: COMPARATOR
Intervention: Placebo-controlled trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Proven effective treatment
Number of subjects: 0
Study: 11737326

Group type: EXPERIMENTAL
Intervention: Immediate antiretroviral treatment (zidovudine)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Deferred antiretroviral treatment (placebo)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Overall trial experience
Number of subjects: 133
Study: 7503048

Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP)
Number of subjects: 19698

Group type: EXPERIMENTAL
Intervention: Diastolic Blood Pressure (DBP)
Number of subjects: 19698

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment
Number of subjects: 19698

Group type: EXPERIMENTAL
Intervention: Upper 40% of SBP distribution
Number of subjects: 19698
Study: 1967416

Group type: EXPERIMENTAL
Intervention: Home-based bicycle exercise training
Number of subjects: 11

Group type: COMPARATOR
Intervention: Activity restriction (rest)
Number of subjects: 11
Study: 365795

Group type: EXPERIMENTAL
Intervention: Viminol (70 mg)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Viminol (70 mg) combined with chlordiazepoxide (10 mg)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Chlordiazepoxide (10 mg)
Number of subjects: 41
Study: 30213641

Group type: EXPERIMENTAL
Intervention: Selective information (incomplete/biased toward repeat caesarean) and relative risk formats (e.g., 2.5 times higher)
Number of subjects: 669

Group type: COMPARATOR
Intervention: Non-selective information (complete/unbiased) and absolute risk formats (e.g., 0.01 per 100)
Number of subjects: 669
Study: 30408717

Group type: EXPERIMENTAL
Intervention: LCHF diet (less than 20g carbohydrates per day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: LCHF diet
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (habitual diet ad libitum)
Number of subjects: 30
Study: 26482893

Group type: EXPERIMENTAL
Intervention: Mild hypoxia at 12,000 ft
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Breathing 100% oxygen after mild hypoxia
Number of subjects: 36

Group type: COMPARATOR
Intervention: Mild hypoxia at 8000 ft
Number of subjects: 36
Study: 24571621

Group type: EXPERIMENTAL
Intervention: Modified assertive intervention based on the international assertive community treatment model
Number of subjects: 29

Group type: COMPARATOR
Intervention: Standard care according to the model of service delivery in this region
Number of subjects: 29
Study: 22207490

Group type: EXPERIMENTAL
Intervention: Fentanyl (FE, 1-2 μg/kg)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Sensorial saturation (SS)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Facilitated tucking (FT)
Number of subjects: 150
Study: 20100959

Group type: EXPERIMENTAL
Intervention: PROSTVAC-VF plus granulocyte-macrophage colony-stimulating factor
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control empty vectors plus saline injections
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: PROSTVAC-VF
Number of subjects: 125
Study: 17331667

Group type: EXPERIMENTAL
Intervention: Three-dimensional conformal radiotherapy (3D-CRT)
Number of subjects: 268
Study: 16279894

Group type: EXPERIMENTAL
Intervention: Steroid injection (0.5 cc/quadrant triamcinolone 40 mg/cc)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 30
Study: 12601292

Group type: EXPERIMENTAL
Intervention: Low carbohydrate bar (Atkins Advantage Bar, LC)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Moderate carbohydrate bar (Balance Bar, MC)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High carbohydrate bar (Power Bar, HC)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Chicken breast (CHI)
Number of subjects: 20

Group type: COMPARATOR
Intervention: White bread (WB)
Number of subjects: 20
Study: 10972455

Group type: EXPERIMENTAL
Intervention: Negative mood condition (distressing or depressing Mood Induction Procedure)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Neutral mood condition (control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: All conditions (following exposure to alcohol cue)
Number of subjects: 40
Study: 10162773

Group type: EXPERIMENTAL
Intervention: Bayesian statistics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Frequentist statistics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Historical controls
Number of subjects: 0

Group type: COMPARATOR
Intervention: Patient choice and autonomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Good statistical techniques
Number of subjects: 0
Study: 2050230

Group type: EXPERIMENTAL
Intervention: Topical retinoic acid 0.01%, 0.025%, or 0.05% applied for 10 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of triamcinolone acetonide 0.1% and retinoic acid 0.025%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Triamcinolone acetonide 0.1% alone
Number of subjects: 0
Study: 6342544

Group type: EXPERIMENTAL
Intervention: Combined treatment of salbutamol (inhalational powder and tablets)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Tablet treatment of salbutamol
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Inhalational powder treatment of salbutamol
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combined treatment of salbutamol
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combined or tablet treatment of salbutamol
Number of subjects: 18
Study: 29401114

Group type: EXPERIMENTAL
Intervention: Supervised exercise training for 12 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 18
Study: 27434745

Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (2600m)
Number of subjects: 36
Study: 24743971

Group type: EXPERIMENTAL
Intervention: Hypertonic saline
Number of subjects: 30

Group type: COMPARATOR
Intervention: Isotonic saline
Number of subjects: 30
Study: 22234381

Group type: EXPERIMENTAL
Intervention: 3 mg of risperidone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1 mg of risperidone
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 21143864

Group type: EXPERIMENTAL
Intervention: Program of rehabilitative exercise and education (PREVENT)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Usual care (USUAL CARE)
Number of subjects: 250
Study: 17413949

Group type: EXPERIMENTAL
Intervention: Linoleic acid (28.5 mg) and gamma-linolenic acid (15 mg) once daily
Number of subjects: 57

Group type: COMPARATOR
Intervention: Eyelid hygiene once daily
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Both linoleic acid and eyelid hygiene
Number of subjects: 57
Study: 15677576

Group type: EXPERIMENTAL
Intervention: PHQ-9 score > or =10
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: PHQ-9
Number of subjects: 316
Study: 12406263

Group type: EXPERIMENTAL
Intervention: Practical skills tutorial in Year 3 (3-hour session on injection and suturing techniques)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Control group (no tutorial)
Number of subjects: 185
Study: 9612217

Group type: EXPERIMENTAL
Intervention: Ramipril therapy
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 8160532

Group type: EXPERIMENTAL
Intervention: Pulsatile measurement of plasma GnRH
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Pulsatile measurement of plasma CRF
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Correlation analysis of GnRH and CRF pulses
Number of subjects: 25
Study: 3281211

Group type: EXPERIMENTAL
Intervention: Randomized phase III protocol for advanced soft-tissue sarcoma
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Improved surgical techniques for extremity sarcomas
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Systemic metastasis management
Number of subjects: 750
Study: 30180918

Group type: EXPERIMENTAL
Intervention: Oxytocin (36 IU BID, supervised administration 45 min prior to CBSST sessions)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Social Skills Training (CBSST)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 29609999

Group type: EXPERIMENTAL
Intervention: 5% Benzoyl Peroxide (BPO)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 4% Chlorhexidine Soap (CHS)
Number of subjects: 40
Study: 26874557

Group type: EXPERIMENTAL
Intervention: Clonidine 300 μg oral premedication administered 90 minutes before surgery
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 24444140

Group type: EXPERIMENTAL
Intervention: Brief psychodynamic psychotherapy (eight sessions administered at two-week intervals)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Usual care (clinical interview, neurological examination, counselling, symptomatic therapy)
Number of subjects: 33
Study: 22468627

Group type: EXPERIMENTAL
Intervention: Immediate release (IR) sodium nitrite
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Enteric-coated (EC) sodium nitrite
Number of subjects: 12
Study: 20305040

Group type: EXPERIMENTAL
Intervention: 0.02% BAC
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 0.05% BAC
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 0.08% BAC
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 0.10% BAC
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Active auditory oddball
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Passive auditory oddball
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Dual-task condition
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (0.00% BAC)
Number of subjects: 32
Study: 17056220

Group type: EXPERIMENTAL
Intervention: 1% N-chlorotaurine (NCT) solution, local irrigations once daily until the canal was dry
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard postoperative procedure (control group)
Number of subjects: 10
Study: 16331769

Group type: EXPERIMENTAL
Intervention: Topical diclofenac diethylamine gel, 1.16%, 4 g applied qid for 3 weeks
Number of subjects: 238

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 238
Study: 11964340

Group type: EXPERIMENTAL
Intervention: Training package of four half days on brief cognitive behaviour therapy
Number of subjects: 272

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 272
Study: 9609775

Group type: EXPERIMENTAL
Intervention: Continuous negative-pressure breathing (CNPB)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control condition (without CNPB)
Number of subjects: 7
Study: 8008822

Group type: EXPERIMENTAL
Intervention: Glass-ionomer cement
Number of subjects: 45

Group type: COMPARATOR
Intervention: Zinc phosphate cement
Number of subjects: 45
Study: 2499178

Group type: EXPERIMENTAL
Intervention: Radiation therapy plus intradermal immunization with viral oncolysate (VO)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Radiation therapy (RT) alone
Number of subjects: 75
Study: 1138642

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 300

Group type: COMPARATOR
Intervention: Low-dose heparin
Number of subjects: 300

Group type: COMPARATOR
Intervention: Combination of low-dose heparin and hydrocortisone
Number of subjects: 300
Study: 7378674

Group type: EXPERIMENTAL
Intervention: Iotroxamide infusion at rates of 0.525 to 6.3 mg/kg/min
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Iotroxamide infusion at an optimal rate of around 4 mg/kg/min
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Iotroxamide infusion
Number of subjects: 24
Study: 30232538

Group type: COMPARATOR
Intervention: Multi-faceted patient and physician educational intervention (active control arm)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Nurse-led case manager (study arm)
Number of subjects: 131
Study: 27828786

Group type: EXPERIMENTAL
Intervention: Tetanic stimulation (group T)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 50
Study: 26269566

Group type: EXPERIMENTAL
Intervention: l-alanyl-l-glutamine (8 g/d) and polyunsaturated fatty acid (6.5 g/d)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo (safflower oil and milk powder)
Number of subjects: 31
Study: 24223963

Group type: EXPERIMENTAL
Intervention: Forward digit recall
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Backward digit recall
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Forward letter recall
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Backward letter recall
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Verbal short-term memory
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Verbal working memory
Number of subjects: 37